Morgan Stanley Downgrades IMS Health (RX) to Underweight

September 25, 2008 7:42 AM EDT

Morgan Stanley downgrades IMS Health (NYSE: RX) from Equalweight to Underweight. Price target $18.

IMS Health Incorporated (IMS) is a provider of market intelligence to the pharmaceutical and healthcare industries.


Related Categories

Downgrades

Stocks Mentioned

RX 21.01

+0.00 +0.00%
Volume: 8,512,741
Track RX


Related Entities


Add Your Comment